| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 2 genes, 1 drug (DrugBank), 5 diseases shown |
[2] PML, RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 2 | Adherens junction 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 3 | Adipocytokine signaling pathway 5 genes, 2 drugs (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 4 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 5 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 6 | Alcoholism 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 7 | Aldosterone synthesis and secretion 3 genes, 3 drugs (DrugBank), 15 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] CYP11B2 |
D11061 |
Osilodrostat |
[1] 75 |
| [1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 8 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] NR3C2 |
D01115 |
Eplerenone |
[3] 75, 113, 215 |
| 9 | AMPK signaling pathway 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 10 | Apelin signaling pathway 3 genes, 2 drugs (DrugBank), 22 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 11 | Autophagy - animal 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 12 | Bile secretion 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] RXRA |
D03106 |
Bexarotene |
[2] 13, 75 |
| 13 | Bladder cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 14 | Breast cancer 3 genes, 3 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] PGR |
D00585 |
Mifepristone |
[1] 75 |
| 15 | Calcium signaling pathway 3 genes, 3 drugs (DrugBank), 8 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 16 | cAMP signaling pathway 6 genes, 5 drugs (DrugBank), 19 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] GLP1R |
D06404 |
Liraglutide |
[3] 6, 75, 193 |
| [1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| [3] SSTR1, SSTR2, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 17 | Central carbon metabolism in cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 18 | cGMP-PKG signaling pathway 2 genes, 2 drugs (DrugBank), 11 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] PDE5A |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| 19 | Choline metabolism in cancer 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 20 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 21 | Cocaine addiction 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 22 | Colorectal cancer 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 23 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] F8 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| 24 | Cortisol synthesis and secretion 4 genes, 4 drugs (DrugBank), 16 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] CYP11B1 |
D00410 |
Metyrapone |
[2] 75, 193 |
| D05019 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 25 | Cushing syndrome 7 genes, 8 drugs (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [2] CRHR1, CRHR2 |
D03905 |
Corticorelin |
[2] 75, 78 |
| D03592 |
Corticorelin ovine triflutate |
[1] 75 |
| [1] CYP11B1 |
D00410 |
Metyrapone |
[2] 75, 193 |
| D05019 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| 26 | Cytokine-cytokine receptor interaction 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] PRL |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 27 | Dopaminergic synapse 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 28 | EGFR tyrosine kinase inhibitor resistance 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 29 | Endocrine resistance 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 30 | Endocytosis 2 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 31 | Endometrial cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 33 | ErbB signaling pathway 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 34 | Estrogen signaling pathway 3 genes, 4 drugs (DrugBank), 7 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] PGR |
D00585 |
Mifepristone |
[1] 75 |
| [1] RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 35 | Fluid shear stress and atherosclerosis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 36 | Focal adhesion 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 37 | FoxO signaling pathway 3 genes, 3 drugs (DrugBank), 19 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 38 | Gap junction 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 39 | Gastric acid secretion 1 gene, 2 drugs (DrugBank), 9 diseases shown |
[1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| D10147 |
Pasireotide |
[3] 67, 74, 75 |
| 40 | Gastric cancer 6 genes, 4 drugs (DrugBank), 8 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 41 | Glioma 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 42 | Glucagon signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 43 | GnRH signaling pathway 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 44 | Growth hormone synthesis, secretion and action 5 genes, 3 drugs (DrugBank), 23 diseases shown |
[1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 45 | Hepatitis C 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] RXRA |
D03106 |
Bexarotene |
[2] 13, 75 |
| 46 | Hepatocellular carcinoma 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 47 | Herpes simplex virus 1 infection 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 48 | HIF-1 signaling pathway 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 49 | Human cytomegalovirus infection 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 50 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 51 | Huntington disease 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 52 | Hypertrophic cardiomyopathy (HCM) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 53 | Influenza A 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 54 | Insulin resistance 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 55 | Insulin secretion 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] GLP1R |
D06404 |
Liraglutide |
[3] 6, 75, 193 |
| 56 | Insulin signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 57 | JAK-STAT signaling pathway 3 genes, 4 drugs (DrugBank), 20 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] PRL |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 58 | Long-term depression 1 gene, 2 drugs (DrugBank), 2 diseases shown |
[1] CRHR1 |
D03905 |
Corticorelin |
[2] 75, 78 |
| D03592 |
Corticorelin ovine triflutate |
[1] 75 |
| 59 | Longevity regulating pathway 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 60 | Longevity regulating pathway - multiple species 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 61 | MAPK signaling pathway 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 62 | Melanoma 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 63 | Metabolic pathways 4 genes, 4 drugs (DrugBank), 9 diseases shown |
[1] CYP11B1 |
D00410 |
Metyrapone |
[2] 75, 193 |
| D05019 |
| [1] CYP11B2 |
D11061 |
Osilodrostat |
[1] 75 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [1] PDE5A |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| 64 | MicroRNAs in cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 65 | mTOR signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 66 | Neuroactive ligand-receptor interaction 14 genes, 16 drugs (DrugBank), 66 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| [2] CRHR1, CRHR2 |
D03905 |
Corticorelin |
[2] 75, 78 |
| D03592 |
Corticorelin ovine triflutate |
[1] 75 |
| [2] DRD2, PRL |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [1] GLP1R |
D06404 |
Liraglutide |
[3] 6, 75, 193 |
| [1] MC2R |
D00146 |
Corticotropin |
[12] 2, 13, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 |
| [1] NR3C1 |
D00292 |
Dexamethasone |
[20] 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| D00088 |
Hydrocortisone |
[8] 6, 53, 75, 78, 81, 83, 97, 299 |
| D00165 |
Hydrocortisone acetate |
[8] 6, 53, 75, 78, 81, 83, 97, 299 |
| D00585 |
Mifepristone |
[1] 75 |
| D00472 |
Prednisolone |
[38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D11336 |
Relacorilant |
[1] 75 |
| [4] SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
[3] 67, 74, 75 |
| [1] SSTR2 |
D00442 |
Octreotide |
[8] 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 67 | Non-alcoholic fatty liver disease (NAFLD) 3 genes, 2 drugs (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] RXRA |
D03106 |
Bexarotene |
[2] 13, 75 |
| 68 | Non-small cell lung cancer 6 genes, 4 drugs (DrugBank), 8 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 69 | Oocyte meiosis 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PGR |
D00585 |
Mifepristone |
[1] 75 |
| 70 | Osteoclast differentiation 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| 71 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 72 | Oxytocin signaling pathway 3 genes, 3 drugs (DrugBank), 19 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 73 | Pancreatic cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 74 | Parathyroid hormone synthesis, secretion and action 4 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 75 | Parkinson disease 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 76 | Pathways in cancer 10 genes, 6 drugs (DrugBank), 16 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [3] PML, RARA, RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 77 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 78 | Phospholipase D signaling pathway 3 genes, 4 drugs (DrugBank), 13 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 79 | PI3K-Akt signaling pathway 7 genes, 6 drugs (DrugBank), 30 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [1] GHR |
D02691 |
Somatotropin |
[18] 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] PRL |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] RXRA |
D03106 |
Bexarotene |
[2] 13, 75 |
| 80 | Platinum drug resistance 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 81 | PPAR signaling pathway 4 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 82 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] PGR |
D00585 |
Mifepristone |
[1] 75 |
| 83 | Prolactin signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| [1] PRL |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| 84 | Prostate cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 85 | Protein digestion and absorption 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] DPP4 |
D08516 |
Sitagliptin |
[3] 75, 233, 299 |
| 86 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| [2] EGFR, ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 87 | Purine metabolism 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] PDE5A |
D02008 |
Tadalafil |
[6] 6, 51, 75, 84, 86, 113 |
| 88 | Rap1 signaling pathway 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] DRD2 |
D00987 |
Cabergoline |
[3] 6, 74, 75 |
| [1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 89 | Ras signaling pathway 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 90 | Regulation of actin cytoskeleton 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 91 | Relaxin signaling pathway 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 92 | Renin secretion 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 93 | Renin-angiotensin system 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 94 | Shigellosis 1 gene, 2 drugs (DrugBank), 3 diseases shown |
[1] EGFR |
D01977 |
Gefitinib |
[1] 75 |
| D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| 95 | Small cell lung cancer 4 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] RARB |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 96 | Steroid hormone biosynthesis 3 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] CYP11B1 |
D00410 |
Metyrapone |
[2] 75, 193 |
| D05019 |
| [1] CYP11B2 |
D11061 |
Osilodrostat |
[1] 75 |
| [1] CYP17A1 |
D00351 |
Ketoconazole |
[3] 8, 13, 75 |
| 97 | Th17 cell differentiation 4 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 98 | Thermogenesis 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 99 | Thyroid cancer 4 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 100 | Thyroid hormone signaling pathway 3 genes, 1 drug (DrugBank), 2 diseases shown |
[3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 101 | Tight junction 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] ERBB2 |
D04024 |
Lapatinib |
[3] 34, 74, 75 |
| D08108 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 102 | Transcriptional misregulation in cancer 6 genes, 3 drugs (DrugBank), 10 diseases shown |
[2] PML, RARA |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| [1] PPARG |
D00596 |
Rosiglitazone |
[5] 46, 75, 97, 222, 265 |
| D08491 |
| [3] RXRA, RXRB, RXRG |
D03106 |
Bexarotene |
[2] 13, 75 |
| 103 | Ubiquitin mediated proteolysis 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] PML |
D00094 |
Tretinoin |
[5] 2, 63, 75, 94, 231 |
| 104 | Vascular smooth muscle contraction 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AGTR1 |
D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 105 | Vasopressin-regulated water reabsorption 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |